Navigation Links
Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders
Date:5/20/2013

GENEVA, May 21, 2013 /PRNewswire/ --

 

  • Campaign launched during World Health Assembly, where world's health ministers gather to address the large physical and economic costs of these disorders
  • Mental and neurological disorders (MNDs) affect 700 million people annually and account for 30 percent of global non-communicable disease (NCD) burden
  • 'Do You Mind?' helps patients, family members, policymakers and others to understand the role each can play to collectively address MNDs

Today the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launched the 'Do You Mind?' campaign to focus attention and to prompt action on MNDs. The campaign launch takes place at the start of the 66th World Health Assembly, where health ministers meet to consider a global mental health action plan.

'Do You Mind?' leverages various profiles to help patients, physicians, employers, policymakers, and the general public understand the role each actor can play in collectively addressing MNDs. Also interactive questioning is used to highlight the impact of MNDs across society, reduce stigma, and dispel common myths.

The World Health Organization reports that 700 million cases of MNDs occur annually and that MNDs account for 30 percent of the global non-communicable disease (NCD) burden. MNDs include schizophrenia, epilepsy, Alzheimer's disease, and depression, which alone affects more than 350 million people. In addition to the personal toll, MNDs have a large socio-economic cost: 40 percent of lost worker productivity in OECD countries is attributable to MNDs.[1]

"More than just a health issue, MNDs should be a societal priority involving decision makers from education, employment, science, government and other spheres," said Eduardo Pisani , IFPMA Director General. "'Do You Mind?' brings these actors together by showing how everybody can act to collectively reduce suffering."

The campaign is publicly available and can be accessed at: http://www.DoYouMindCampaign.org

About the IFPMA:

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

--------------------------------------------------

1. 'Sick on the Job? Myths and Realities about Mental Health and Work.' OECD. 2012 


'/>"/>
SOURCE IFPMA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
9. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... 22, 2017  Lilac Corp, the company that ... launch of a new website . The ... a clinical study that showed surprising clearance of ... in individuals suffering from HPV warts, precancerous, or ... are no other treatments that clear the virus. ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/12/2017)... -- The China and Canada joint tech company Laughing ... energy and detergent, and features a powerful disinfection process. ... machine that washes and sanitizes women,s panties or babies, cloth diapers ... ... not require an external water inlet. ...
Breaking Medicine Technology:
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... London, May ... honored to serve earlier this month as a Guest Speaker and Contributor to a ... Royal Family and Common Purpose. , Walter Schindler and SAIL ...
(Date:5/23/2017)... Rosa, CA (PRWEB) , ... May 23, 2017 , ... ... mosquito season underway in Sonoma County. While officials call for diligence, asking homeowners to ... are looking at potential health concerns. Along with the annoying buzz of mosquitos is ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... leading equipment provider in the modern ART laboratory, to provide hands-on training utilizing ... Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing vendor , will ...
(Date:5/23/2017)... ... , ... New patients from Charleston, SC, are now welcome to receive a ... SC, with or without a referral. A full mouth reconstruction can transform the appearance ... in Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw pain ...
(Date:5/23/2017)... ... 2017 , ... New patients with symptoms of gum disease in ... gum disease treatments from the doctors at Art of Dentistry, without first receiving a ... the importance of receiving qualified treatment in order to avoid systemic health effects associated ...
Breaking Medicine News(10 mins):